Skip to main content
HGYN
OTC Industrial Applications And Services

Hong Yuan Q2 Revenue Collapses 71% as Losses Widen and Equity Turns Negative

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.037
Mkt Cap
$2.762M
52W Low
$0
52W High
$0.24
52W Position
Off High info
85% below high
Rel. Volume
Market data snapshot near publication time

Summary

Hong Yuan's Q2 2026 revenue dropped 71% to $32,161, losses widened to $94,404, and equity turned negative at -$146,510. Going concern risk is acute with only $13,365 in cash.


Key Events · Earnings and Guidance · HGYN

  • Revenue Collapses 71%

    Q2 2026 revenue was $32,161 versus $112,812 in Q2 2025, driven by declining Chinese VIE revenue. Six-month revenue fell from $353,877 to $75,858.

  • Losses Widen Sharply

    Net loss to the company was $94,404 in Q2 2026 versus net income of $30,042 a year earlier. Six-month loss was $187,750 versus income of $67,542.

  • Equity Turns Negative

    Total equity (deficit) fell from positive $19,646 at December 31, 2025 to negative $146,510 at June 30, 2026. Working capital deficit was $174,082.

  • Going Concern Risk Acute

    Management reiterates substantial doubt about continuing as a going concern. Cash on hand is only $13,365, and the company relies on non-binding advances from its majority shareholder.


Analysis · HGYN · Industrial Applications And Services

Hong Yuan Holding Group's Q2 2026 results show accelerating deterioration. Revenue fell 71.5% year-over-year to just $32,161, while operating expenses more than doubled to $116,939. The company swung from a $30,042 profit in Q2 2025 to a $94,404 loss. Total equity flipped from positive $19,646 at year-end to a $146,510 deficit, and the working capital deficit reached $174,082. Management reiterates substantial doubt about its ability to continue as a going concern, with only $13,365 in cash on hand. The company is dependent on interest-free advances from its majority shareholder, who has no written obligation to continue funding.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 36.4% of the 1070 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HGYN was trading at $0.04 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $2.8M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HGYN - Latest Insights

HGYN
Sep 14, 2026, 1:28 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Price at Filing: $0.037
Real-time Price: $0.037 info
Change: $0 (0%) info
Market Cap: $2.762M info
HGYN
Jun 22, 2026, 5:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0358
Real-time Price: $0.037 info
Change: +$0.0012 (+3%) info
Market Cap: $2.762M info
HGYN
May 08, 2026, 3:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.098
Real-time Price: $0.037 info
Change: -$0.061 (-62%) info
Market Cap: $2.762M info